

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.69115411 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 6.69115411 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 6.69115411 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 6.69115411 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.69115411 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.69115411 |
| 7 | positive regulation of interferon-alpha production (GO:0032727) | 5.49608782 |
| 8 | response to interferon-alpha (GO:0035455) | 5.39966543 |
| 9 | * type I interferon signaling pathway (GO:0060337) | 5.39891284 |
| 10 | * cellular response to type I interferon (GO:0071357) | 5.39891284 |
| 11 | * response to type I interferon (GO:0034340) | 5.39113902 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.36204992 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.36204992 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.26811434 |
| 15 | regulation of interferon-alpha production (GO:0032647) | 5.21476798 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.17733326 |
| 17 | response to host immune response (GO:0052572) | 4.98880602 |
| 18 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.98880602 |
| 19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.90888894 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.86978104 |
| 21 | macrophage activation involved in immune response (GO:0002281) | 4.81915972 |
| 22 | response to peptidoglycan (GO:0032494) | 4.77498928 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 4.67963303 |
| 24 | response to host (GO:0075136) | 4.52187883 |
| 25 | response to host defenses (GO:0052200) | 4.52187883 |
| 26 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.52187883 |
| 27 | neutrophil activation involved in immune response (GO:0002283) | 4.43721010 |
| 28 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.09026719 |
| 29 | positive regulation of interferon-beta production (GO:0032728) | 4.07939665 |
| 30 | negative regulation of viral genome replication (GO:0045071) | 4.03892615 |
| 31 | positive regulation of antigen processing and presentation (GO:0002579) | 4.01552790 |
| 32 | negative regulation of T cell mediated immunity (GO:0002710) | 3.98850446 |
| 33 | detection of bacterium (GO:0016045) | 3.93783008 |
| 34 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.87614434 |
| 35 | positive regulation of type 2 immune response (GO:0002830) | 3.85729343 |
| 36 | response to muramyl dipeptide (GO:0032495) | 3.85519891 |
| 37 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.78994764 |
| 38 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.71985097 |
| 39 | regulation of RIG-I signaling pathway (GO:0039535) | 3.70875698 |
| 40 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.70491226 |
| 41 | response to interferon-beta (GO:0035456) | 3.70164515 |
| 42 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.69456437 |
| 43 | microglial cell activation (GO:0001774) | 3.64581168 |
| 44 | cellular response to virus (GO:0098586) | 3.63252125 |
| 45 | regulation of viral genome replication (GO:0045069) | 3.63147629 |
| 46 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.61199230 |
| 47 | myeloid cell activation involved in immune response (GO:0002275) | 3.61183404 |
| 48 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.59430655 |
| 49 | detection of molecule of bacterial origin (GO:0032490) | 3.58578353 |
| 50 | regulation of gamma-delta T cell activation (GO:0046643) | 3.58073262 |
| 51 | natural killer cell mediated immunity (GO:0002228) | 3.57683062 |
| 52 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.57683062 |
| 53 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.57517137 |
| 54 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.53498811 |
| 55 | defense response to protozoan (GO:0042832) | 3.52273131 |
| 56 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.50439554 |
| 57 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.49078383 |
| 58 | regulation of type 2 immune response (GO:0002828) | 3.47015764 |
| 59 | regulation of T cell tolerance induction (GO:0002664) | 3.44307190 |
| 60 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.43178452 |
| 61 | germinal center formation (GO:0002467) | 3.41982073 |
| 62 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.41597563 |
| 63 | cellular response to interferon-beta (GO:0035458) | 3.41576830 |
| 64 | negative regulation of viral process (GO:0048525) | 3.40560814 |
| 65 | B cell mediated immunity (GO:0019724) | 3.39165805 |
| 66 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.38011158 |
| 67 | I-kappaB phosphorylation (GO:0007252) | 3.37658820 |
| 68 | regulation of antigen processing and presentation (GO:0002577) | 3.37613120 |
| 69 | negative thymic T cell selection (GO:0045060) | 3.30506438 |
| 70 | respiratory burst (GO:0045730) | 3.27575426 |
| 71 | response to interleukin-15 (GO:0070672) | 3.27560134 |
| 72 | negative regulation of interleukin-12 production (GO:0032695) | 3.26366532 |
| 73 | negative regulation of type 2 immune response (GO:0002829) | 3.26265161 |
| 74 | positive regulation of B cell differentiation (GO:0045579) | 3.21848637 |
| 75 | myeloid dendritic cell differentiation (GO:0043011) | 3.21638955 |
| 76 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.21401538 |
| 77 | * defense response to virus (GO:0051607) | 3.20482452 |
| 78 | macrophage activation (GO:0042116) | 3.20243141 |
| 79 | response to protozoan (GO:0001562) | 3.19866107 |
| 80 | granulocyte activation (GO:0036230) | 3.18302208 |
| 81 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.17865305 |
| 82 | * response to interferon-gamma (GO:0034341) | 3.17763530 |
| 83 | negative T cell selection (GO:0043383) | 3.17507250 |
| 84 | cellular response to interleukin-15 (GO:0071350) | 3.14825109 |
| 85 | neutrophil activation (GO:0042119) | 3.14293615 |
| 86 | lymphocyte chemotaxis (GO:0048247) | 3.11965153 |
| 87 | leukocyte aggregation (GO:0070486) | 3.11656343 |
| 88 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.10675925 |
| 89 | T cell migration (GO:0072678) | 3.10578705 |
| 90 | natural killer cell activation involved in immune response (GO:0002323) | 3.10439545 |
| 91 | regulation of tolerance induction (GO:0002643) | 3.10413381 |
| 92 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.09747497 |
| 93 | negative regulation of cell killing (GO:0031342) | 3.09625461 |
| 94 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.09625461 |
| 95 | negative regulation of innate immune response (GO:0045824) | 3.07192525 |
| 96 | NIK/NF-kappaB signaling (GO:0038061) | 3.07058460 |
| 97 | cellular response to exogenous dsRNA (GO:0071360) | 3.05867598 |
| 98 | cellular response to interferon-alpha (GO:0035457) | 3.04040230 |
| 99 | myeloid dendritic cell activation (GO:0001773) | 3.02415761 |
| 100 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.01392879 |
| 101 | T-helper 1 type immune response (GO:0042088) | 3.01172234 |
| 102 | regulation of interferon-beta production (GO:0032648) | 3.00700964 |
| 103 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.00281274 |
| 104 | detection of other organism (GO:0098543) | 2.99938506 |
| 105 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.97948358 |
| 106 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.93062047 |
| 107 | interferon-gamma secretion (GO:0072643) | 2.91686852 |
| 108 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.91610315 |
| 109 | mature B cell differentiation (GO:0002335) | 2.91449060 |
| 110 | positive regulation of defense response to virus by host (GO:0002230) | 2.91344506 |
| 111 | regulation of interleukin-12 production (GO:0032655) | 2.90029405 |
| 112 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.89278403 |
| 113 | tolerance induction (GO:0002507) | 2.88689808 |
| 114 | pinocytosis (GO:0006907) | 2.88601392 |
| 115 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.88474844 |
| 116 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.88129782 |
| 117 | positive regulation of response to biotic stimulus (GO:0002833) | 2.88076368 |
| 118 | * cellular response to interferon-gamma (GO:0071346) | 2.87490553 |
| 119 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.87215220 |
| 120 | positive regulation of humoral immune response (GO:0002922) | 2.85576398 |
| 121 | detection of external biotic stimulus (GO:0098581) | 2.85239801 |
| 122 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.80796446 |
| 123 | B cell receptor signaling pathway (GO:0050853) | 2.78631223 |
| 124 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.78413422 |
| 125 | neutrophil mediated immunity (GO:0002446) | 2.78171983 |
| 126 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.78125990 |
| 127 | positive regulation of interleukin-17 production (GO:0032740) | 2.76095190 |
| 128 | regulation of interleukin-17 production (GO:0032660) | 2.75141589 |
| 129 | regulation of mast cell degranulation (GO:0043304) | 2.74969707 |
| 130 | regulation of B cell differentiation (GO:0045577) | 2.74425870 |
| 131 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.72806060 |
| 132 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.72268328 |
| 133 | detection of biotic stimulus (GO:0009595) | 2.72176253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.42219500 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.33268375 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.26777685 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.54791170 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.26689995 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.16158953 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.85475973 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.71830458 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.54428026 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.42519851 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.10885217 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.94891797 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.86431883 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.79076739 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.64062857 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.62147645 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.57234982 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.54456516 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.54129220 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.47203310 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.18759401 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.17321418 |
| 23 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.10596311 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00417302 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.99197401 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.95211353 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.93220711 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.86482694 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 1.86022553 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.82874554 |
| 31 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.78213487 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77359497 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.77338518 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.76252818 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.71377446 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.70827526 |
| 37 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.70532379 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.67377333 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.64742404 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.56191935 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.54666010 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51320467 |
| 43 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47377376 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45518147 |
| 45 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40144543 |
| 46 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37939078 |
| 47 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.37693359 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.35595601 |
| 49 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35400919 |
| 50 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.31578514 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31364125 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.29446363 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28363385 |
| 54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27471361 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.23921868 |
| 56 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.16159690 |
| 57 | MYC_22102868_ChIP-Seq_BL_Human | 1.13985710 |
| 58 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13671670 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12022381 |
| 60 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.11987798 |
| 61 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.11078456 |
| 62 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10368985 |
| 63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09802386 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08686683 |
| 65 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.08020519 |
| 66 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.07930728 |
| 67 | MAF_26560356_Chip-Seq_TH2_Human | 1.05356064 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05324183 |
| 69 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04614783 |
| 70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03996516 |
| 71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03877162 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03504554 |
| 73 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02144035 |
| 74 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01586419 |
| 75 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99961406 |
| 76 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.96791488 |
| 77 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.95316041 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95054983 |
| 79 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.93364513 |
| 80 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93046198 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92814156 |
| 82 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91329028 |
| 83 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.88470018 |
| 84 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.86758286 |
| 85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.85189608 |
| 86 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84204555 |
| 87 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83372686 |
| 88 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.83101136 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.81204832 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81143928 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81036444 |
| 92 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.80782042 |
| 93 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.80623490 |
| 94 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80384603 |
| 95 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.78647243 |
| 96 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.78012978 |
| 97 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.76920318 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.76803214 |
| 99 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.76151075 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.72915382 |
| 101 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.72474279 |
| 102 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.72165860 |
| 103 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.69221537 |
| 104 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.68925936 |
| 105 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.68039898 |
| 106 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.65756071 |
| 107 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64694211 |
| 108 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.64592328 |
| 109 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.64339308 |
| 110 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.64150659 |
| 111 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63638375 |
| 112 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.63133320 |
| 113 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.63133320 |
| 114 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.63004246 |
| 115 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.61068553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.26523247 |
| 2 | MP0009785_altered_susceptibility_to | 3.64869832 |
| 3 | MP0003436_decreased_susceptibility_to | 3.36321595 |
| 4 | MP0001790_abnormal_immune_system | 3.02429401 |
| 5 | MP0005387_immune_system_phenotype | 3.02429401 |
| 6 | MP0005025_abnormal_response_to | 3.00341008 |
| 7 | MP0000569_abnormal_digit_pigmentation | 2.99339234 |
| 8 | MP0000685_abnormal_immune_system | 2.98538016 |
| 9 | MP0002419_abnormal_innate_immunity | 2.90947280 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.90095932 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.89285531 |
| 12 | MP0003303_peritoneal_inflammation | 2.82915470 |
| 13 | MP0003724_increased_susceptibility_to | 2.80960717 |
| 14 | MP0001800_abnormal_humoral_immune | 2.72757602 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.67490607 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.59612244 |
| 17 | MP0002723_abnormal_immune_serum | 2.52866335 |
| 18 | MP0006082_CNS_inflammation | 2.50038133 |
| 19 | MP0004510_myositis | 2.41573953 |
| 20 | MP0005671_abnormal_response_to | 2.36248894 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.26432015 |
| 22 | MP0001819_abnormal_immune_cell | 2.22691915 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.20657711 |
| 24 | MP0004947_skin_inflammation | 2.18709699 |
| 25 | MP0003172_abnormal_lysosome_physiology | 2.16701034 |
| 26 | MP0009278_abnormal_bone_marrow | 2.15275574 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.92674194 |
| 28 | MP0002166_altered_tumor_susceptibility | 1.83662542 |
| 29 | MP0002396_abnormal_hematopoietic_system | 1.79967766 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.78229525 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.78228110 |
| 32 | MP0002405_respiratory_system_inflammati | 1.76797849 |
| 33 | MP0002398_abnormal_bone_marrow | 1.74676352 |
| 34 | MP0005451_abnormal_body_composition | 1.74662731 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 1.73590018 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.73590018 |
| 37 | MP0009840_abnormal_foam_cell | 1.73164485 |
| 38 | MP0000716_abnormal_immune_system | 1.72688199 |
| 39 | MP0008469_abnormal_protein_level | 1.69427665 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.68984985 |
| 41 | MP0001853_heart_inflammation | 1.68115948 |
| 42 | MP0005174_abnormal_tail_pigmentation | 1.64353581 |
| 43 | MP0002006_tumorigenesis | 1.58284766 |
| 44 | MP0000343_altered_response_to | 1.56866644 |
| 45 | MP0000689_abnormal_spleen_morphology | 1.54736303 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.54142900 |
| 47 | MP0003448_altered_tumor_morphology | 1.48822252 |
| 48 | MP0009764_decreased_sensitivity_to | 1.46928272 |
| 49 | MP0002429_abnormal_blood_cell | 1.43523858 |
| 50 | MP0003763_abnormal_thymus_physiology | 1.41759062 |
| 51 | MP0004808_abnormal_hematopoietic_stem | 1.39210285 |
| 52 | MP0002722_abnormal_immune_system | 1.36915900 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.30802930 |
| 54 | MP0003075_altered_response_to | 1.30230575 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.24856955 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.24366448 |
| 57 | MP0010307_abnormal_tumor_latency | 1.22981203 |
| 58 | MP0001873_stomach_inflammation | 1.22406154 |
| 59 | MP0000604_amyloidosis | 1.19684376 |
| 60 | MP0009763_increased_sensitivity_to | 1.17279349 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.14603105 |
| 62 | MP0000858_altered_metastatic_potential | 1.12780937 |
| 63 | MP0008260_abnormal_autophagy | 1.10931009 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 1.03340321 |
| 65 | MP0003566_abnormal_cell_adhesion | 1.02147542 |
| 66 | MP0000015_abnormal_ear_pigmentation | 1.01898288 |
| 67 | MP0001851_eye_inflammation | 1.01808271 |
| 68 | MP0005310_abnormal_salivary_gland | 1.00419231 |
| 69 | MP0002933_joint_inflammation | 1.00042677 |
| 70 | MP0002254_reproductive_system_inflammat | 0.96177852 |
| 71 | MP0005167_abnormal_blood-brain_barrier | 0.94808219 |
| 72 | MP0002332_abnormal_exercise_endurance | 0.93038609 |
| 73 | MP0003828_pulmonary_edema | 0.92671390 |
| 74 | MP0000371_diluted_coat_color | 0.92624161 |
| 75 | MP0001958_emphysema | 0.92557555 |
| 76 | MP0003806_abnormal_nucleotide_metabolis | 0.92498743 |
| 77 | MP0008004_abnormal_stomach_pH | 0.91270914 |
| 78 | MP0005023_abnormal_wound_healing | 0.88912523 |
| 79 | MP0004883_abnormal_blood_vessel | 0.88786858 |
| 80 | MP0005166_decreased_susceptibility_to | 0.88273906 |
| 81 | MP0005390_skeleton_phenotype | 0.88226381 |
| 82 | MP0000703_abnormal_thymus_morphology | 0.86230516 |
| 83 | MP0002277_abnormal_respiratory_mucosa | 0.81761160 |
| 84 | MP0000249_abnormal_blood_vessel | 0.81015158 |
| 85 | MP0001348_abnormal_lacrimal_gland | 0.80999141 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.80798319 |
| 87 | MP0000490_abnormal_crypts_of | 0.80219090 |
| 88 | MP0005076_abnormal_cell_differentiation | 0.79166434 |
| 89 | MP0001663_abnormal_digestive_system | 0.74608595 |
| 90 | MP0004381_abnormal_hair_follicle | 0.74488239 |
| 91 | MP0005164_abnormal_response_to | 0.74423918 |
| 92 | MP0002132_abnormal_respiratory_system | 0.74236786 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.74076686 |
| 94 | MP0004782_abnormal_surfactant_physiolog | 0.73026474 |
| 95 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70949969 |
| 96 | MP0003690_abnormal_glial_cell | 0.70176224 |
| 97 | MP0003866_abnormal_defecation | 0.69416351 |
| 98 | MP0002139_abnormal_hepatobiliary_system | 0.69328191 |
| 99 | MP0008874_decreased_physiological_sensi | 0.67961966 |
| 100 | MP0003091_abnormal_cell_migration | 0.66145922 |
| 101 | MP0008438_abnormal_cutaneous_collagen | 0.64942657 |
| 102 | MP0003045_fibrosis | 0.63265874 |
| 103 | MP0009765_abnormal_xenobiotic_induced | 0.62386823 |
| 104 | MP0000609_abnormal_liver_physiology | 0.61998569 |
| 105 | MP0010352_gastrointestinal_tract_polyps | 0.60507068 |
| 106 | MP0002136_abnormal_kidney_physiology | 0.59586651 |
| 107 | MP0005075_abnormal_melanosome_morpholog | 0.59296545 |
| 108 | MP0005083_abnormal_biliary_tract | 0.59111457 |
| 109 | MP0003795_abnormal_bone_structure | 0.58924095 |
| 110 | MP0002095_abnormal_skin_pigmentation | 0.58395812 |
| 111 | MP0006054_spinal_hemorrhage | 0.56316324 |
| 112 | MP0002019_abnormal_tumor_incidence | 0.55693767 |
| 113 | MP0000767_abnormal_smooth_muscle | 0.55304813 |
| 114 | MP0002693_abnormal_pancreas_physiology | 0.55018329 |
| 115 | MP0001881_abnormal_mammary_gland | 0.52048981 |
| 116 | MP0000920_abnormal_myelination | 0.51151176 |
| 117 | MP0002163_abnormal_gland_morphology | 0.49307941 |
| 118 | MP0002877_abnormal_melanocyte_morpholog | 0.49086658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.46616718 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.89182017 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.68137911 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.94678853 |
| 5 | Myositis (HP:0100614) | 4.65052788 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.53434311 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.36688017 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.25400179 |
| 9 | Chronic otitis media (HP:0000389) | 4.23193596 |
| 10 | Autoimmune thrombocytopenia (HP:0001973) | 4.14584587 |
| 11 | Orchitis (HP:0100796) | 4.12278192 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.03925999 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.93854933 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.93219006 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 3.92971655 |
| 16 | Recurrent skin infections (HP:0001581) | 3.80411455 |
| 17 | Optic neuritis (HP:0100653) | 3.76201118 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 3.76201118 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.67197105 |
| 20 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.64622746 |
| 21 | Recurrent viral infections (HP:0004429) | 3.61776209 |
| 22 | Prostate neoplasm (HP:0100787) | 3.60736872 |
| 23 | Encephalitis (HP:0002383) | 3.53788497 |
| 24 | T lymphocytopenia (HP:0005403) | 3.53771515 |
| 25 | Abnormality of T cell number (HP:0011839) | 3.50925673 |
| 26 | Gingivitis (HP:0000230) | 3.50308021 |
| 27 | Periodontitis (HP:0000704) | 3.50099031 |
| 28 | Stomatitis (HP:0010280) | 3.50092196 |
| 29 | Vasculitis (HP:0002633) | 3.49067730 |
| 30 | Pustule (HP:0200039) | 3.14593360 |
| 31 | Loss of speech (HP:0002371) | 3.13013345 |
| 32 | Nasal polyposis (HP:0100582) | 3.02926359 |
| 33 | Basal ganglia calcification (HP:0002135) | 2.96621356 |
| 34 | Agammaglobulinemia (HP:0004432) | 2.96421340 |
| 35 | Abnormality of T cells (HP:0002843) | 2.93303504 |
| 36 | Panhypogammaglobulinemia (HP:0003139) | 2.89161086 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 2.88329602 |
| 38 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.88329602 |
| 39 | Abnormality of the nasal mucosa (HP:0000433) | 2.87122400 |
| 40 | Gingival bleeding (HP:0000225) | 2.84929384 |
| 41 | Recurrent bronchitis (HP:0002837) | 2.82025240 |
| 42 | Interstitial pulmonary disease (HP:0006530) | 2.81313432 |
| 43 | Cellulitis (HP:0100658) | 2.78227671 |
| 44 | Lymphopenia (HP:0001888) | 2.77288330 |
| 45 | Glomerulonephritis (HP:0000099) | 2.76617539 |
| 46 | Gangrene (HP:0100758) | 2.75825950 |
| 47 | Thick nail (HP:0001805) | 2.74245909 |
| 48 | Colitis (HP:0002583) | 2.73529495 |
| 49 | Chronic obstructive pulmonary disease (HP:0006510) | 2.73028986 |
| 50 | Obstructive lung disease (HP:0006536) | 2.73028986 |
| 51 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.70633606 |
| 52 | Premature loss of primary teeth (HP:0006323) | 2.67217954 |
| 53 | Arterial thrombosis (HP:0004420) | 2.63600714 |
| 54 | Disinhibition (HP:0000734) | 2.63203700 |
| 55 | Axonal loss (HP:0003447) | 2.61017347 |
| 56 | Pulmonary infiltrates (HP:0002113) | 2.59294984 |
| 57 | Osteomyelitis (HP:0002754) | 2.57186328 |
| 58 | Abnormality of the pleura (HP:0002103) | 2.56219791 |
| 59 | Anorexia (HP:0002039) | 2.55317609 |
| 60 | Abnormality of T cell physiology (HP:0011840) | 2.55003534 |
| 61 | Dysostosis multiplex (HP:0000943) | 2.53661255 |
| 62 | Inflammation of the large intestine (HP:0002037) | 2.51566011 |
| 63 | Pulmonary embolism (HP:0002204) | 2.51177269 |
| 64 | Hematochezia (HP:0002573) | 2.50780002 |
| 65 | Increased IgE level (HP:0003212) | 2.50267780 |
| 66 | IgG deficiency (HP:0004315) | 2.49124185 |
| 67 | Abnormality of the prostate (HP:0008775) | 2.45682396 |
| 68 | IgA deficiency (HP:0002720) | 2.45105452 |
| 69 | Prolonged bleeding time (HP:0003010) | 2.44738405 |
| 70 | Meningitis (HP:0001287) | 2.43809217 |
| 71 | Granulocytopenia (HP:0001913) | 2.42907915 |
| 72 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.42361197 |
| 73 | Osteolytic defects of the hand bones (HP:0009699) | 2.42361197 |
| 74 | Leukocytosis (HP:0001974) | 2.41414218 |
| 75 | Recurrent sinusitis (HP:0011108) | 2.41336925 |
| 76 | Gastrointestinal inflammation (HP:0004386) | 2.40779303 |
| 77 | Epistaxis (HP:0000421) | 2.37653683 |
| 78 | Hypergammaglobulinemia (HP:0010702) | 2.36347273 |
| 79 | Keratoconjunctivitis sicca (HP:0001097) | 2.36296983 |
| 80 | Urticaria (HP:0001025) | 2.36044964 |
| 81 | Hemoptysis (HP:0002105) | 2.35971304 |
| 82 | Abnormality of the endocardium (HP:0004306) | 2.34769120 |
| 83 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.33527146 |
| 84 | Abnormality of B cell number (HP:0010975) | 2.32586632 |
| 85 | Spontaneous hematomas (HP:0007420) | 2.29028754 |
| 86 | Joint swelling (HP:0001386) | 2.26136953 |
| 87 | Nephritis (HP:0000123) | 2.24843005 |
| 88 | Petechiae (HP:0000967) | 2.24433664 |
| 89 | IgM deficiency (HP:0002850) | 2.20895276 |
| 90 | Sepsis (HP:0100806) | 2.18136772 |
| 91 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.17420339 |
| 92 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.17420339 |
| 93 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.17420339 |
| 94 | Emphysema (HP:0002097) | 2.14766220 |
| 95 | Abnormality of the pericardium (HP:0001697) | 2.14030231 |
| 96 | Purpura (HP:0000979) | 2.13697145 |
| 97 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.13457962 |
| 98 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.13457962 |
| 99 | Abnormality of glycolipid metabolism (HP:0010969) | 2.13457962 |
| 100 | Gastrointestinal stroma tumor (HP:0100723) | 2.13435362 |
| 101 | Keratoconjunctivitis (HP:0001096) | 2.13376620 |
| 102 | Skin rash (HP:0000988) | 2.13014161 |
| 103 | Chronic diarrhea (HP:0002028) | 2.12900544 |
| 104 | Cheilitis (HP:0100825) | 2.12657465 |
| 105 | Pathologic fracture (HP:0002756) | 2.12604056 |
| 106 | Mucopolysacchariduria (HP:0008155) | 2.12347749 |
| 107 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.12347749 |
| 108 | Glomerulopathy (HP:0100820) | 2.12269230 |
| 109 | Amaurosis fugax (HP:0100576) | 2.12256732 |
| 110 | Arthralgia (HP:0002829) | 2.12020433 |
| 111 | Hypochromic anemia (HP:0001931) | 2.10811675 |
| 112 | Polyneuropathy (HP:0001271) | 2.10782462 |
| 113 | B lymphocytopenia (HP:0010976) | 2.10265280 |
| 114 | Tetraparesis (HP:0002273) | 2.09669332 |
| 115 | Absent frontal sinuses (HP:0002688) | 2.05402538 |
| 116 | Chronic sinusitis (HP:0011109) | 2.05349923 |
| 117 | Eosinophilia (HP:0001880) | 2.01819300 |
| 118 | Skin ulcer (HP:0200042) | 2.01677535 |
| 119 | Keratitis (HP:0000491) | 2.01532384 |
| 120 | Recurrent pneumonia (HP:0006532) | 2.01419734 |
| 121 | Porencephaly (HP:0002132) | 2.01395030 |
| 122 | Abnormality of the fingertips (HP:0001211) | 1.99504485 |
| 123 | Gastrointestinal infarctions (HP:0005244) | 1.99186132 |
| 124 | Bone pain (HP:0002653) | 1.98948484 |
| 125 | Restrictive lung disease (HP:0002091) | 1.95374781 |
| 126 | Neoplasm of head and neck (HP:0012288) | 1.94891958 |
| 127 | Esophageal neoplasm (HP:0100751) | 1.94891958 |
| 128 | Increased IgM level (HP:0003496) | 1.94781782 |
| 129 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.93843582 |
| 130 | Myocardial infarction (HP:0001658) | 1.93579943 |
| 131 | Chest pain (HP:0100749) | 1.91740974 |
| 132 | Autoimmune hemolytic anemia (HP:0001890) | 1.91222043 |
| 133 | Thrombocytosis (HP:0001894) | 1.87184953 |
| 134 | Vertebral compression fractures (HP:0002953) | 1.85983775 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TYK2 | 4.35617087 |
| 2 | KIT | 3.83040073 |
| 3 | IKBKE | 3.61248034 |
| 4 | TBK1 | 3.46667762 |
| 5 | MAP3K14 | 3.35461697 |
| 6 | MAP4K1 | 3.28218147 |
| 7 | IRAK4 | 2.90868791 |
| 8 | PRPF4B | 2.88673264 |
| 9 | RIPK4 | 2.79804245 |
| 10 | JAK1 | 2.64351639 |
| 11 | BLK | 2.60328637 |
| 12 | IRAK3 | 2.55046320 |
| 13 | ERN1 | 2.52318970 |
| 14 | JAK3 | 2.51556642 |
| 15 | TXK | 2.36370196 |
| 16 | TAOK3 | 2.02068296 |
| 17 | IKBKB | 1.95255155 |
| 18 | MAP3K13 | 1.89594062 |
| 19 | FGFR4 | 1.88111440 |
| 20 | ZAP70 | 1.72580161 |
| 21 | CSF1R | 1.64975018 |
| 22 | TEC | 1.61510087 |
| 23 | CSK | 1.60914975 |
| 24 | HCK | 1.59675415 |
| 25 | BTK | 1.54553438 |
| 26 | SYK | 1.52490542 |
| 27 | EPHB1 | 1.52021237 |
| 28 | GRK7 | 1.51725369 |
| 29 | FLT3 | 1.49823550 |
| 30 | TTN | 1.43563692 |
| 31 | FES | 1.40286823 |
| 32 | TGFBR2 | 1.39437272 |
| 33 | TNK2 | 1.38812842 |
| 34 | LCK | 1.28640415 |
| 35 | CHUK | 1.22396863 |
| 36 | TAOK2 | 1.19156994 |
| 37 | CAMK1D | 1.18910882 |
| 38 | PIM2 | 1.15421412 |
| 39 | MATK | 1.11783550 |
| 40 | FGFR3 | 1.11215738 |
| 41 | LYN | 1.10044585 |
| 42 | NEK9 | 0.99960292 |
| 43 | CDC42BPA | 0.97767521 |
| 44 | PIM1 | 0.96554046 |
| 45 | SMG1 | 0.96141391 |
| 46 | TAOK1 | 0.95648447 |
| 47 | MAP2K3 | 0.95476662 |
| 48 | FGR | 0.94299838 |
| 49 | JAK2 | 0.93094815 |
| 50 | NME2 | 0.92900591 |
| 51 | STK10 | 0.92235482 |
| 52 | RIPK1 | 0.88411858 |
| 53 | MAP3K11 | 0.87823229 |
| 54 | CDK12 | 0.87753359 |
| 55 | RPS6KA4 | 0.86845944 |
| 56 | PTK6 | 0.85961187 |
| 57 | MAP3K10 | 0.85733800 |
| 58 | SIK2 | 0.85692695 |
| 59 | ITK | 0.82837492 |
| 60 | MAP3K1 | 0.80793179 |
| 61 | STK24 | 0.78097521 |
| 62 | CAMK1G | 0.74063740 |
| 63 | PKN2 | 0.73927900 |
| 64 | EIF2AK2 | 0.73637729 |
| 65 | EPHA3 | 0.73469070 |
| 66 | MAPK7 | 0.71248921 |
| 67 | TESK2 | 0.67802963 |
| 68 | MARK3 | 0.65574353 |
| 69 | CLK1 | 0.63213639 |
| 70 | DDR2 | 0.60947780 |
| 71 | EGFR | 0.59957620 |
| 72 | TRPM7 | 0.58263465 |
| 73 | GRK6 | 0.57529875 |
| 74 | MAPK11 | 0.56667487 |
| 75 | IRAK2 | 0.56600851 |
| 76 | NLK | 0.56156298 |
| 77 | STK4 | 0.55466432 |
| 78 | DAPK2 | 0.54975374 |
| 79 | MAP3K5 | 0.54673781 |
| 80 | TGFBR1 | 0.53536266 |
| 81 | ABL1 | 0.52226697 |
| 82 | MOS | 0.51186689 |
| 83 | TIE1 | 0.50275395 |
| 84 | LRRK2 | 0.49886435 |
| 85 | MAP3K3 | 0.49692840 |
| 86 | CDK6 | 0.49240087 |
| 87 | ACVR1B | 0.47205780 |
| 88 | PRKCD | 0.43688992 |
| 89 | IRAK1 | 0.43637076 |
| 90 | RPS6KA6 | 0.43519789 |
| 91 | PRKD2 | 0.42486411 |
| 92 | PDPK1 | 0.42476662 |
| 93 | STK3 | 0.41120055 |
| 94 | YES1 | 0.39818992 |
| 95 | MST1R | 0.39077860 |
| 96 | KSR2 | 0.38649824 |
| 97 | CDK4 | 0.38070849 |
| 98 | FYN | 0.36206189 |
| 99 | MARK2 | 0.32261947 |
| 100 | DAPK3 | 0.31751639 |
| 101 | PIK3CG | 0.31542229 |
| 102 | HIPK2 | 0.31346966 |
| 103 | MAPK12 | 0.31101429 |
| 104 | CDK19 | 0.29710081 |
| 105 | ADRBK2 | 0.29640059 |
| 106 | MAPKAPK2 | 0.29455216 |
| 107 | PRKCH | 0.27551871 |
| 108 | KDR | 0.27020815 |
| 109 | PDK1 | 0.26991469 |
| 110 | MELK | 0.26267703 |
| 111 | ATR | 0.25746860 |
| 112 | PRKG2 | 0.25465683 |
| 113 | IGF1R | 0.25118647 |
| 114 | MAP2K6 | 0.24904243 |
| 115 | PRKCQ | 0.24685509 |
| 116 | MAPK3 | 0.24421002 |
| 117 | DYRK1B | 0.24014412 |
| 118 | RPS6KL1 | 0.23905551 |
| 119 | RPS6KC1 | 0.23905551 |
| 120 | CAMKK2 | 0.23887181 |
| 121 | TRIB3 | 0.23800980 |
| 122 | BMPR2 | 0.23642088 |
| 123 | MAPK4 | 0.23281192 |
| 124 | SIK1 | 0.23177605 |
| 125 | SIK3 | 0.20746165 |
| 126 | BMX | 0.19576289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.25966238 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.18118235 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.91842616 |
| 4 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.87372944 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.82207400 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.69344568 |
| 7 | * Measles_Homo sapiens_hsa05162 | 2.57485104 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.49019893 |
| 9 | * Influenza A_Homo sapiens_hsa05164 | 2.30860120 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 2.28427643 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.22005663 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.18674839 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.17724453 |
| 14 | Malaria_Homo sapiens_hsa05144 | 2.14095476 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.10376480 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.03108766 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 2.01597448 |
| 18 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.97732804 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.80493757 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79392504 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.78467565 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.76764767 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.75775592 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.72253223 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.70245073 |
| 26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.65774533 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.61432475 |
| 28 | Lysosome_Homo sapiens_hsa04142 | 1.59189290 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.57059340 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.54168946 |
| 31 | Asthma_Homo sapiens_hsa05310 | 1.54153009 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.52862066 |
| 33 | * Hepatitis C_Homo sapiens_hsa05160 | 1.48185447 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.45531670 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.39099233 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.37459684 |
| 37 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.36571994 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.35409123 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.33634207 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.32468647 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.27132742 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23968275 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.21805114 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.20647288 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.10487748 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09081650 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08569901 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.96224012 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93931704 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92444436 |
| 51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88890412 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84195586 |
| 53 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.84172705 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.83447776 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82132681 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79305681 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.79170676 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76228737 |
| 59 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70882439 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70583550 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68503613 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67082121 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67081435 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64647369 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63925025 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61220583 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.59895585 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58090298 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55713991 |
| 70 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55664985 |
| 71 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.54826863 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53201900 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.52395542 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50995001 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48761245 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48386580 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45133579 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39436161 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38716564 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38314403 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32794854 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30102641 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | 0.29372604 |
| 84 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29147404 |
| 85 | Lysine degradation_Homo sapiens_hsa00310 | 0.29093803 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.28063373 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27622210 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.27186699 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24358394 |
| 90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.23810264 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.23568186 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.23088970 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.22681738 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.22442682 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22062726 |
| 96 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.21303705 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.21030922 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.18759322 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.16526698 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.16224173 |
| 101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.16099624 |
| 102 | Endometrial cancer_Homo sapiens_hsa05213 | 0.15447793 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.15231178 |
| 104 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.14964182 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.14931314 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.13239158 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.13081828 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.12700990 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.12045384 |
| 110 | Focal adhesion_Homo sapiens_hsa04510 | 0.11316680 |
| 111 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.11151981 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.10656992 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.10509511 |

